RPS6KA1 and pancreatic adenocarcinoma: Both RSK1 and RSK2 had high mRNA expression in acute myeloid leukemia (LAML), GBM, pancreatic adenocarcinoma (PAAD), and stomach adenocarcinoma (STAD) patient data.